Antagonistic, synergistic, and additive antibacterial interaction between ciprofloxacin and amoxicillin against Staphylococcus aureus

Fundam Clin Pharmacol. 2023 Feb;37(1):174-181. doi: 10.1111/fcp.12832. Epub 2022 Sep 20.

Abstract

The aim of this in vitro study was to evaluate the interaction between ciprofloxacin and amoxicillin against beta-lactamase-producing Staphylococcus aureus. Concentration-dependent curves for each individual drug were carried out to obtain the mean inhibitory concentration in the agar well diffusion assay. Then, different ratios of the ciprofloxacin-amoxicillin combination (0.5:0.5, 0.8:0.2, 0.2:0.8, 0.9:0.1, 0.1:0.9, 0.95:0.05, and 0.05:0.95) were assessed. Data were analyzed using the isobolographic analysis and interaction index. The isobolographic evaluation shows that the 0.9:0.1 and 0.95:0.05 ratios of the ciprofloxacin-amoxicillin combination produced a synergistic antimicrobial interaction, the 0.8:0.2, 0.2:0.8, 0.1:0.9, and 0.05:0.95 proportions showed an additive antibacterial effect, and the 0.5:0.5 proportion induced antagonistic antimicrobial effects. The interaction index showed similar outcomes to the isobolographic analysis. In conclusion, the data of this study mainly show antimicrobial additive results of the ciprofloxacin-amoxicillin combination against beta-lactamase-producing S. aureus.

Keywords: Staphylococcus aureus; amoxicillin; antimicrobial interaction; ciprofloxacin.

MeSH terms

  • Amoxicillin / pharmacology
  • Anti-Bacterial Agents / pharmacology
  • Ciprofloxacin* / pharmacology
  • Drug Synergism
  • Humans
  • Microbial Sensitivity Tests
  • Staphylococcal Infections* / drug therapy
  • Staphylococcus aureus
  • beta-Lactamases / pharmacology

Substances

  • Ciprofloxacin
  • Amoxicillin
  • Anti-Bacterial Agents
  • beta-Lactamases